Janssen Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JANSSEN THERAP, and what generic alternatives to JANSSEN THERAP drugs are available?
JANSSEN THERAP has one approved drug.
There are two US patents protecting JANSSEN THERAP drugs.
There are eighty-seven patent family members on JANSSEN THERAP drugs in thirty-nine countries and eighteen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Janssen Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-002 | May 27, 2020 | RX | Yes | No | 7,498,343 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-002 | May 27, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-001 | Dec 28, 2012 | RX | Yes | Yes | 8,546,428 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-002 | May 27, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Janssen Therap | SIRTURO | bedaquiline fumarate | TABLET;ORAL | 204384-001 | Dec 28, 2012 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Janssen Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 2086940 | ⤷ Sign Up |
Brazil | PI0719693 | ⤷ Sign Up |
European Patent Office | 1527050 | ⤷ Sign Up |
Argentina | 040673 | ⤷ Sign Up |
Serbia | 20050058 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Janssen Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1527050 | PA2014032 | Lithuania | ⤷ Sign Up | PRODUCT NAME: BEDAQUILINUM; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
1527050 | CA 2014 00044 | Denmark | ⤷ Sign Up | PRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE-ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305 |
1527050 | 122014000083 | Germany | ⤷ Sign Up | PRODUCT NAME: BEDAQUILIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEURE- ODER BASENADDITIONSSALZ DAVON; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
1527050 | 178 5021-2014 | Slovakia | ⤷ Sign Up | PRODUCT NAME: BEDACHILIN FUMARAT; REGISTRATION NO/DATE: EU/1/13/901 20140305 |
1527050 | C20140026 00112 | Estonia | ⤷ Sign Up | PRODUCT NAME: BEDAKVILIIN;REG NO/DATE: K(2014)1616 (LOPLIK) 07.03.2014 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.